H.Res.709 - Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.113th Congress (2013-2014)
All Actions: H.Res.709 — 113th Congress (2013-2014)All Information (Except Text)
3 results for All Actions | Compact View
|08/01/2014||Referred to the Subcommittee on Health.|
|07/31/2014||Referred to the House Committee on Energy and Commerce.|
|07/31/2014||Introduced in House|
08/01/2014 Referred to the Subcommittee on Health.
07/31/2014 Referred to the House Committee on Energy and Commerce.
07/31/2014 Introduced in House